| embryonic camera type eye formation | GO:0060900 | 2 | 0.999 | |
| smooth muscle cell differentiation | GO:0051145 | 8 | 0.958 | |
| protein dna complex disassembly | GO:0032986 | 12 | 0.958 | Human |
| neuroblast proliferation | GO:0007405 | 4 | 0.929 | |
| nucleosome disassembly | GO:0006337 | 12 | 0.927 | Human |
| protein complex disassembly | GO:0043241 | 52 | 0.905 | Human |
| chromatin disassembly | GO:0031498 | 13 | 0.896 | Human |
| nucleosome organization | GO:0034728 | 66 | 0.896 | Human |
| chromatin assembly or disassembly | GO:0006333 | 78 | 0.842 | Human |
| atp dependent chromatin remodeling | GO:0043044 | 25 | 0.820 | |
| viral process | GO:0016032 | 146 | 0.811 | |
| sex determination | GO:0007530 | 3 | 0.807 | |
| vascular smooth muscle cell differentiation | GO:0035886 | 3 | 0.763 | |
| nucleosome positioning | GO:0016584 | 3 | 0.754 | |
| viral life cycle | GO:0019058 | 132 | 0.727 | |
| chromatin remodeling at centromere | GO:0031055 | 2 | 0.716 | |
| positive regulation of viral transcription | GO:0050434 | 13 | 0.715 | |
| alcohol metabolic process | GO:0006066 | 114 | 0.693 | |
| macromolecular complex disassembly | GO:0032984 | 60 | 0.689 | Human |
| negative regulation of neural precursor cell proliferation | GO:2000178 | 1 | 0.671 | |
| positive regulation of cell fate commitment | GO:0010455 | 2 | 0.671 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.630 | |
| embryonic camera type eye morphogenesis | GO:0048596 | 2 | 0.623 | |
| post embryonic development | GO:0009791 | 2 | 0.623 | |
| chromatin modification | GO:0016568 | 298 | 0.601 | Human |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 0.599 | Human |
| hindbrain development | GO:0030902 | 3 | 0.596 | |
| protein dna complex subunit organization | GO:0071824 | 80 | 0.593 | Human |
| embryonic eye morphogenesis | GO:0048048 | 2 | 0.570 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.565 | |
| androgen receptor signaling pathway | GO:0030521 | 34 | 0.559 | Human |
| histone h3 acetylation | GO:0043966 | 45 | 0.515 | |
| oligosaccharide metabolic process | GO:0009311 | 13 | 0.513 | |
| positive regulation of viral process | GO:0048524 | 37 | 0.503 | |
| dna recombination | GO:0006310 | 77 | 0.500 | |
| multi organism cellular process | GO:0044764 | 156 | 0.477 | |
| cardiac muscle tissue development | GO:0048738 | 39 | 0.463 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.461 | |
| interspecies interaction between organisms | GO:0044419 | 156 | 0.415 | |
| regulation of viral transcription | GO:0046782 | 34 | 0.414 | |
| viral gene expression | GO:0019080 | 35 | 0.409 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.396 | |
| intracellular estrogen receptor signaling pathway | GO:0030520 | 23 | 0.396 | Human |
| embryonic camera type eye development | GO:0031076 | 2 | 0.391 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 9 | 0.373 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.362 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.361 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 156 | 0.361 | |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO:0051817 | 38 | 0.360 | |
| small molecule catabolic process | GO:0044282 | 92 | 0.360 | |
| cellular carbohydrate metabolic process | GO:0044262 | 84 | 0.356 | |
| viral transcription | GO:0019083 | 35 | 0.352 | |
| neuron differentiation | GO:0030182 | 138 | 0.338 | |
| chromatin organization | GO:0006325 | 351 | 0.335 | Human |
| positive regulation of developmental process | GO:0051094 | 314 | 0.333 | |
| regulation of viral process | GO:0050792 | 103 | 0.329 | |
| cellular response to starvation | GO:0009267 | 58 | 0.326 | |
| cardiac chamber development | GO:0003205 | 30 | 0.322 | |
| neural tube formation | GO:0001841 | 3 | 0.315 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.313 | |
| negative regulation of cell cycle g1 s phase transition | GO:1902807 | 29 | 0.312 | |
| epithelium development | GO:0060429 | 227 | 0.305 | |
| regulation of cell development | GO:0060284 | 161 | 0.290 | |
| primary neural tube formation | GO:0014020 | 3 | 0.287 | |
| cell fate determination | GO:0001709 | 3 | 0.284 | |
| neuron fate commitment | GO:0048663 | 2 | 0.283 | |
| definitive erythrocyte differentiation | GO:0060318 | 2 | 0.260 | |
| regulation of neuroblast proliferation | GO:1902692 | 3 | 0.257 | |
| chromatin assembly | GO:0031497 | 61 | 0.252 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.249 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.245 | |
| multi organism metabolic process | GO:0044033 | 41 | 0.244 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 158 | 0.241 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.237 | |
| forebrain generation of neurons | GO:0021872 | 3 | 0.232 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.226 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.225 | |
| chromatin remodeling | GO:0006338 | 55 | 0.225 | Human |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.224 | |
| base excision repair | GO:0006284 | 21 | 0.221 | |
| strand invasion | GO:0042148 | 2 | 0.216 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.212 | |
| neuron projection development | GO:0031175 | 106 | 0.211 | |
| cellular component disassembly | GO:0022411 | 92 | 0.206 | Human |
| chemotaxis | GO:0006935 | 157 | 0.204 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.202 | |
| positive regulation of epidermal growth factor receptor signaling pathway | GO:0045742 | 11 | 0.199 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.196 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.196 | |
| modification of morphology or physiology of other organism | GO:0035821 | 43 | 0.194 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.193 | |
| forebrain neuron differentiation | GO:0021879 | 3 | 0.192 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 109 | 0.192 | |
| pharyngeal system development | GO:0060037 | 2 | 0.191 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.187 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.185 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 78 | 0.184 | |
| tube closure | GO:0060606 | 3 | 0.182 | |
| carbohydrate catabolic process | GO:0016052 | 36 | 0.179 | |
| regulation of cell growth | GO:0001558 | 135 | 0.178 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.177 | |
| positive regulation of erbb signaling pathway | GO:1901186 | 11 | 0.175 | |
| interaction with symbiont | GO:0051702 | 26 | 0.173 | |
| negative regulation of chromatin silencing | GO:0031936 | 4 | 0.172 | |
| histone acetylation | GO:0016573 | 93 | 0.171 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.170 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.170 | |
| oogenesis | GO:0048477 | 2 | 0.169 | |
| tube morphogenesis | GO:0035239 | 95 | 0.167 | |
| macromolecule methylation | GO:0043414 | 97 | 0.167 | |
| positive regulation of dna metabolic process | GO:0051054 | 73 | 0.167 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.165 | |
| cellular response to external stimulus | GO:0071496 | 111 | 0.159 | |
| nervous system development | GO:0007399 | 293 | 0.159 | |
| cerebellum development | GO:0021549 | 2 | 0.155 | |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.155 | |
| brain development | GO:0007420 | 97 | 0.147 | |
| regulation of gene expression epigenetic | GO:0040029 | 73 | 0.147 | |
| double strand break repair | GO:0006302 | 101 | 0.144 | |
| circulatory system development | GO:0072359 | 262 | 0.144 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 61 | 0.143 | Human |
| neurogenesis | GO:0022008 | 169 | 0.139 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.137 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 158 | 0.132 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.130 | |
| chromosome segregation | GO:0007059 | 114 | 0.130 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.130 | |
| cell development | GO:0048468 | 328 | 0.128 | |
| locomotory behavior | GO:0007626 | 1 | 0.126 | |
| alcohol catabolic process | GO:0046164 | 20 | 0.124 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.123 | |
| muscle organ development | GO:0007517 | 56 | 0.119 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.119 | |
| female gamete generation | GO:0007292 | 2 | 0.118 | |
| steroid metabolic process | GO:0008202 | 94 | 0.117 | |
| cellular response to nutrient levels | GO:0031669 | 69 | 0.117 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.116 | |
| toxin transport | GO:1901998 | 4 | 0.115 | |
| secretion | GO:0046903 | 254 | 0.114 | |
| endocytosis | GO:0006897 | 159 | 0.114 | |
| dendrite development | GO:0016358 | 24 | 0.113 | |
| neural retina development | GO:0003407 | 8 | 0.111 | |
| regulation of intracellular steroid hormone receptor signaling pathway | GO:0033143 | 32 | 0.111 | |
| organic hydroxy compound metabolic process | GO:1901615 | 147 | 0.111 | |
| negative regulation of intracellular steroid hormone receptor signaling pathway | GO:0033144 | 18 | 0.111 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.110 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 54 | 0.110 | |
| memory | GO:0007613 | 3 | 0.110 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.107 | |
| cardiovascular system development | GO:0072358 | 262 | 0.107 | |
| muscle cell differentiation | GO:0042692 | 63 | 0.105 | |
| muscle structure development | GO:0061061 | 98 | 0.105 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.104 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.104 | |
| vasculature development | GO:0001944 | 181 | 0.103 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 158 | 0.102 | |
| embryonic hindlimb morphogenesis | GO:0035116 | 2 | 0.101 | |
| single organism carbohydrate catabolic process | GO:0044724 | 33 | 0.099 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 186 | 0.098 | |
| neuron development | GO:0048666 | 113 | 0.096 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.096 | |
| modulation of transcription in other organism involved in symbiotic interaction | GO:0052312 | 20 | 0.095 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.095 | |
| positive regulation of chromatin assembly or disassembly | GO:0045799 | 2 | 0.095 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 159 | 0.094 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.094 | |
| visual learning | GO:0008542 | 1 | 0.091 | |
| central nervous system development | GO:0007417 | 123 | 0.091 | |
| modulation by host of symbiont transcription | GO:0052472 | 20 | 0.090 | |
| chromatin mediated maintenance of transcription | GO:0048096 | 2 | 0.090 | |
| erbb signaling pathway | GO:0038127 | 44 | 0.090 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.090 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.089 | |
| modification by host of symbiont morphology or physiology | GO:0051851 | 26 | 0.087 | |
| gonad development | GO:0008406 | 34 | 0.086 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 191 | 0.086 | |
| negative regulation of cell growth | GO:0030308 | 83 | 0.086 | |
| cell morphogenesis | GO:0000902 | 296 | 0.086 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.085 | |
| response to extracellular stimulus | GO:0009991 | 85 | 0.084 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.083 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.083 | |
| atp metabolic process | GO:0046034 | 176 | 0.082 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.082 | |
| multicellular organismal response to stress | GO:0033555 | 1 | 0.082 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.079 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.079 | |
| dna dependent dna replication | GO:0006261 | 44 | 0.079 | |
| negative regulation of stem cell proliferation | GO:2000647 | 3 | 0.079 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 41 | 0.078 | |
| amine metabolic process | GO:0009308 | 44 | 0.078 | |
| atp catabolic process | GO:0006200 | 157 | 0.077 | |
| oligosaccharide catabolic process | GO:0009313 | 4 | 0.075 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.075 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 187 | 0.075 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.074 | |
| muscle tissue development | GO:0060537 | 62 | 0.074 | |
| dna conformation change | GO:0071103 | 113 | 0.074 | |
| taxis | GO:0042330 | 157 | 0.072 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.072 | |
| lipid metabolic process | GO:0006629 | 381 | 0.072 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.071 | |
| biological adhesion | GO:0022610 | 331 | 0.071 | |
| behavior | GO:0007610 | 112 | 0.071 | |
| blastocyst development | GO:0001824 | 3 | 0.070 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 4 | 0.069 | |
| regulation of cell fate commitment | GO:0010453 | 7 | 0.069 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.069 | |
| histone h3 k27 acetylation | GO:0043974 | 2 | 0.069 | |
| negative regulation of growth | GO:0045926 | 97 | 0.069 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.069 | |
| cell substrate adhesion | GO:0031589 | 132 | 0.069 | |
| metencephalon development | GO:0022037 | 2 | 0.068 | |
| cell growth | GO:0016049 | 160 | 0.067 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 186 | 0.066 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.066 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.066 | |
| corticosteroid receptor signaling pathway | GO:0031958 | 5 | 0.065 | Human |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.065 | |
| dna replication | GO:0006260 | 116 | 0.064 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 40 | 0.063 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.063 | |
| cell adhesion | GO:0007155 | 325 | 0.063 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.062 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 18 | 0.061 | |
| response to nutrient levels | GO:0031667 | 81 | 0.061 | |
| tube development | GO:0035295 | 125 | 0.060 | |
| reproductive structure development | GO:0048608 | 55 | 0.059 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.059 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.058 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.058 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.058 | |
| striated muscle tissue development | GO:0014706 | 59 | 0.058 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.057 | |
| cell morphogenesis involved in neuron differentiation | GO:0048667 | 44 | 0.057 | |
| cell projection organization | GO:0030030 | 252 | 0.057 | |
| regulation of single species biofilm formation | GO:1900190 | 2 | 0.056 | |
| neural tube closure | GO:0001843 | 3 | 0.056 | |
| dendrite morphogenesis | GO:0048813 | 14 | 0.056 | |
| positive regulation of multi organism process | GO:0043902 | 56 | 0.055 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.055 | |
| regulation of cell adhesion | GO:0030155 | 166 | 0.055 | |
| heart morphogenesis | GO:0003007 | 48 | 0.054 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.054 | |
| single organism reproductive process | GO:0044702 | 98 | 0.054 | |
| regulation of stem cell proliferation | GO:0072091 | 15 | 0.053 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.053 | |
| gene silencing | GO:0016458 | 49 | 0.053 | |
| generation of neurons | GO:0048699 | 152 | 0.053 | |
| sex differentiation | GO:0007548 | 45 | 0.052 | |
| microtubule based process | GO:0007017 | 210 | 0.052 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 118 | 0.051 | |
| methylation | GO:0032259 | 106 | 0.051 | |
| segmentation | GO:0035282 | 4 | 0.051 | |
| secretion by cell | GO:0032940 | 226 | 0.050 | |
| response to starvation | GO:0042594 | 59 | 0.050 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.050 | |
| histone methylation | GO:0016571 | 60 | 0.050 | |
| ventricular septum morphogenesis | GO:0060412 | 3 | 0.049 | |
| glucocorticoid metabolic process | GO:0008211 | 10 | 0.049 | |
| epidermis morphogenesis | GO:0048730 | 3 | 0.049 | |
| regulation of cell substrate adhesion | GO:0010810 | 68 | 0.048 | |
| protein acylation | GO:0043543 | 138 | 0.048 | |
| cell cycle g1 s phase transition | GO:0044843 | 80 | 0.048 | |
| metal ion transport | GO:0030001 | 272 | 0.046 | |
| spermatid differentiation | GO:0048515 | 4 | 0.046 | |
| oxidation reduction process | GO:0055114 | 396 | 0.046 | |
| peptidyl lysine modification | GO:0018205 | 144 | 0.045 | |
| striated muscle cell differentiation | GO:0051146 | 43 | 0.045 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.044 | |
| modulation by host of viral transcription | GO:0043921 | 20 | 0.044 | |
| chordate embryonic development | GO:0043009 | 34 | 0.044 | |
| internal peptidyl lysine acetylation | GO:0018393 | 97 | 0.044 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.043 | |
| glucocorticoid receptor signaling pathway | GO:0042921 | 5 | 0.043 | Human |
| blastoderm segmentation | GO:0007350 | 2 | 0.043 | |
| single organism cellular localization | GO:1902580 | 332 | 0.042 | |
| growth | GO:0040007 | 202 | 0.042 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.042 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.042 | |
| spermatid development | GO:0007286 | 4 | 0.042 | |
| positive regulation of cell adhesion | GO:0045785 | 84 | 0.041 | |
| single stranded viral rna replication via double stranded dna intermediate | GO:0039692 | 9 | 0.041 | |
| cellular response to extracellular stimulus | GO:0031668 | 72 | 0.041 | |
| epithelial tube morphogenesis | GO:0060562 | 38 | 0.040 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.040 | |
| response to hypoxia | GO:0001666 | 96 | 0.039 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 37 | 0.039 | |
| sensory perception of pain | GO:0019233 | 4 | 0.039 | |
| gtp metabolic process | GO:0046039 | 239 | 0.039 | |
| organ morphogenesis | GO:0009887 | 147 | 0.038 | |
| oocyte differentiation | GO:0009994 | 2 | 0.038 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 19 | 0.037 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.037 | |
| smad protein complex assembly | GO:0007183 | 12 | 0.037 | |
| stem cell division | GO:0017145 | 2 | 0.037 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.036 | |
| positive regulation of reproductive process | GO:2000243 | 9 | 0.036 | |
| organelle fission | GO:0048285 | 149 | 0.036 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.036 | |
| glycerophospholipid metabolic process | GO:0006650 | 84 | 0.035 | |
| immune response | GO:0006955 | 307 | 0.035 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.035 | |
| methylation dependent chromatin silencing | GO:0006346 | 3 | 0.035 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.035 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.034 | |
| regulation of erbb signaling pathway | GO:1901184 | 27 | 0.034 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 18 | 0.034 | |
| oocyte development | GO:0048599 | 1 | 0.034 | |
| embryonic organ development | GO:0048568 | 36 | 0.033 | |
| organic hydroxy compound catabolic process | GO:1901616 | 22 | 0.033 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 125 | 0.033 | |
| negative regulation of histone acetylation | GO:0035067 | 6 | 0.033 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.033 | |
| regulation of growth | GO:0040008 | 165 | 0.033 | |
| regulation of bmp signaling pathway | GO:0030510 | 27 | 0.032 | |
| carbon catabolite activation of transcription | GO:0045991 | 3 | 0.032 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.032 | |
| reproductive system development | GO:0061458 | 56 | 0.032 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.032 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 18 | 0.032 | |
| regulation of chromatin modification | GO:1903308 | 51 | 0.031 | |
| cellular carbohydrate catabolic process | GO:0044275 | 17 | 0.031 | |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.031 | |
| embryo development | GO:0009790 | 123 | 0.031 | |
| intracellular protein transport | GO:0006886 | 270 | 0.030 | |
| sensory organ development | GO:0007423 | 52 | 0.030 | |
| phagocytosis | GO:0006909 | 42 | 0.030 | |
| histone modification | GO:0016570 | 251 | 0.029 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.029 | |
| placenta development | GO:0001890 | 10 | 0.028 | |
| nuclear division | GO:0000280 | 128 | 0.028 | |
| response to other organism | GO:0051707 | 261 | 0.028 | |
| blood vessel development | GO:0001568 | 172 | 0.028 | |
| head development | GO:0060322 | 108 | 0.028 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.027 | |
| reproductive process | GO:0022414 | 106 | 0.027 | |
| phospholipid metabolic process | GO:0006644 | 99 | 0.027 | |
| viral genome replication | GO:0019079 | 50 | 0.027 | |
| chromatin silencing | GO:0006342 | 12 | 0.027 | |
| lipid biosynthetic process | GO:0008610 | 177 | 0.027 | |
| cell cell signaling | GO:0007267 | 155 | 0.027 | |
| developmental process involved in reproduction | GO:0003006 | 66 | 0.027 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 98 | 0.026 | |
| cation transport | GO:0006812 | 331 | 0.026 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.026 | |
| regulation of cell projection organization | GO:0031344 | 107 | 0.026 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.026 | |
| respiratory gaseous exchange | GO:0007585 | 3 | 0.025 | |
| dna repair | GO:0006281 | 198 | 0.025 | |
| regulation of locomotion | GO:0040012 | 329 | 0.025 | |
| regulation of heterochromatin assembly | GO:0031445 | 1 | 0.025 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.025 | |
| ion transmembrane transport | GO:0034220 | 338 | 0.025 | |
| system process | GO:0003008 | 349 | 0.025 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.025 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.025 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.024 | |
| divalent inorganic cation homeostasis | GO:0072507 | 136 | 0.024 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.024 | |
| retinal ganglion cell axon guidance | GO:0031290 | 2 | 0.024 | |
| skin development | GO:0043588 | 76 | 0.024 | |
| positive regulation of organic acid transport | GO:0032892 | 3 | 0.024 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.024 | |
| regulation of protein localization | GO:0032880 | 296 | 0.023 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 89 | 0.023 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.023 | |
| camera type eye development | GO:0043010 | 25 | 0.023 | |
| protein catabolic process | GO:0030163 | 325 | 0.023 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.023 | |
| negative regulation of cell development | GO:0010721 | 48 | 0.023 | |
| cell cycle arrest | GO:0007050 | 71 | 0.023 | |
| ion homeostasis | GO:0050801 | 230 | 0.023 | |
| regulation of neurogenesis | GO:0050767 | 82 | 0.023 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.023 | |
| t cell differentiation in thymus | GO:0033077 | 4 | 0.023 | |
| internal protein amino acid acetylation | GO:0006475 | 101 | 0.023 | |
| regulation of secretion | GO:0051046 | 194 | 0.022 | |
| renal tubule development | GO:0061326 | 19 | 0.022 | |
| tripartite regional subdivision | GO:0007351 | 2 | 0.022 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.022 | |
| cardiac right ventricle morphogenesis | GO:0003215 | 3 | 0.022 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.022 | |
| microtubule cytoskeleton organization | GO:0000226 | 176 | 0.022 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 94 | 0.021 | |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.021 | |
| protein acetylation | GO:0006473 | 116 | 0.021 | |
| negative regulation of protein complex assembly | GO:0031333 | 43 | 0.021 | |
| regulation of behavior | GO:0050795 | 82 | 0.021 | |
| eye development | GO:0001654 | 42 | 0.021 | |
| adult locomotory behavior | GO:0008344 | 1 | 0.021 | |
| organelle localization | GO:0051640 | 84 | 0.021 | |
| membrane organization | GO:0061024 | 292 | 0.021 | |
| dna packaging | GO:0006323 | 77 | 0.021 | |
| heterochromatin assembly | GO:0031507 | 6 | 0.021 | |
| chemical homeostasis | GO:0048878 | 306 | 0.021 | |
| regulation of neuron apoptotic process | GO:0043523 | 35 | 0.021 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.021 | |
| regulation of striated muscle tissue development | GO:0016202 | 26 | 0.021 | |
| response to oxygen levels | GO:0070482 | 100 | 0.020 | |
| regulation of respiratory gaseous exchange | GO:0043576 | 2 | 0.020 | |
| regulation of system process | GO:0044057 | 101 | 0.020 | |
| cell cycle g2 m phase transition | GO:0044839 | 43 | 0.020 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.020 | |
| regulation of dna binding | GO:0051101 | 37 | 0.020 | |
| monovalent inorganic cation transport | GO:0015672 | 128 | 0.020 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 156 | 0.020 | |
| prostate gland development | GO:0030850 | 3 | 0.020 | |
| genetic imprinting | GO:0071514 | 1 | 0.020 | |
| synaptic transmission | GO:0007268 | 61 | 0.019 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.019 | |
| endochondral bone morphogenesis | GO:0060350 | 3 | 0.019 | |
| actin mediated cell contraction | GO:0070252 | 12 | 0.019 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 90 | 0.019 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.019 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.019 | |
| epidermal growth factor receptor signaling pathway | GO:0007173 | 39 | 0.019 | |
| myosin filament organization | GO:0031033 | 2 | 0.019 | |
| axon development | GO:0061564 | 34 | 0.019 | |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 162 | 0.019 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 69 | 0.019 | |
| positive regulation of nervous system development | GO:0051962 | 54 | 0.019 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.019 | |
| metal ion homeostasis | GO:0055065 | 169 | 0.019 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.018 | |
| regulation of gtpase activity | GO:0043087 | 180 | 0.018 | |
| single organism membrane organization | GO:0044802 | 268 | 0.018 | |
| protein maturation | GO:0051604 | 233 | 0.018 | |
| negative regulation of transcription initiation from rna polymerase ii promoter | GO:0060633 | 3 | 0.018 | |
| immune response regulating signaling pathway | GO:0002764 | 97 | 0.018 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.018 | |
| eye morphogenesis | GO:0048592 | 16 | 0.018 | |
| inorganic ion transmembrane transport | GO:0098660 | 231 | 0.018 | |
| mrna metabolic process | GO:0016071 | 175 | 0.018 | |
| endosomal transport | GO:0016197 | 129 | 0.018 | |
| negative regulation of protein catabolic process | GO:0042177 | 59 | 0.018 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 42 | 0.018 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.018 | |
| spinal cord development | GO:0021510 | 4 | 0.018 | |
| receptor mediated endocytosis | GO:0006898 | 84 | 0.018 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 17 | 0.018 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 50 | 0.018 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 119 | 0.018 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 83 | 0.018 | |
| sensory perception | GO:0007600 | 103 | 0.017 | |
| somitogenesis | GO:0001756 | 2 | 0.017 | |
| response to light stimulus | GO:0009416 | 87 | 0.017 | |
| cellular response to acid chemical | GO:0071229 | 44 | 0.017 | |
| positive regulation of i kappab kinase nf kappab signaling | GO:0043123 | 132 | 0.017 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.017 | |
| motor neuron axon guidance | GO:0008045 | 2 | 0.017 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 166 | 0.017 | |
| actin filament based process | GO:0030029 | 224 | 0.017 | |
| heart formation | GO:0060914 | 2 | 0.017 | |
| positive regulation of gene expression epigenetic | GO:0045815 | 7 | 0.017 | |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.017 | |
| bone development | GO:0060348 | 26 | 0.017 | |
| embryonic placenta development | GO:0001892 | 1 | 0.017 | |
| cell type specific apoptotic process | GO:0097285 | 125 | 0.017 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.017 | |
| regulation of cell activation | GO:0050865 | 125 | 0.017 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.017 | |
| cellular response to glucocorticoid stimulus | GO:0071385 | 4 | 0.017 | |
| negative regulation of catabolic process | GO:0009895 | 104 | 0.017 | |
| hair cycle | GO:0042633 | 28 | 0.016 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.016 | |
| development of primary sexual characteristics | GO:0045137 | 35 | 0.016 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 185 | 0.016 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.016 | |
| regulation of nervous system development | GO:0051960 | 88 | 0.016 | |
| rho protein signal transduction | GO:0007266 | 26 | 0.016 | |
| meiosis i | GO:0007127 | 4 | 0.016 | |
| embryonic organ morphogenesis | GO:0048562 | 24 | 0.016 | |
| cellular response to lipid | GO:0071396 | 127 | 0.016 | |
| dephosphorylation | GO:0016311 | 209 | 0.016 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.016 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 37 | 0.016 | |
| negative regulation of neurogenesis | GO:0050768 | 26 | 0.016 | |
| regulation of protein catabolic process | GO:0042176 | 155 | 0.016 | |
| nuclear import | GO:0051170 | 106 | 0.016 | |
| calcium ion homeostasis | GO:0055074 | 122 | 0.016 | |
| protein polyubiquitination | GO:0000209 | 110 | 0.016 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.016 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.016 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 186 | 0.016 | |
| neurotransmitter secretion | GO:0007269 | 4 | 0.016 | |
| maintenance of cell polarity | GO:0030011 | 2 | 0.016 | |
| limbic system development | GO:0021761 | 3 | 0.015 | |
